Morgan Morrow, APRN
Acute Care · Little Rock, ARNPI 1366044182
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,971 of the $4,016 with a category attached, or 74.0%. 10 manufacturers reported payments, led by Beone Medicines USA, Inc. at 25.9% of the total. 2025 is the largest year on record at $3,171, more than ten times the $198 reported in 2021.
Across 17 payments — averaging $236.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beone Medicines USA, Inc.$1K
- Sanofi$898
- Novartis$715
- Beigene USA, Inc.$609
- AstraZeneca$175
- Incyte Corporation$165
- plus $415 from 4 others
What the payments were for
- Consulting fees$2,97174%
- Food & beverage$99525%
- Education$501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beone Medicines USA, Inc. | 3 | $1,038 |
| Sanofi | 2 | $898 |
| Novartis | 1 | $715 |
| Beigene USA, Inc. | 4 | $609 |
| AstraZeneca | 1 | $175 |
| Incyte Corporation | 2 | $165 |
| Geron Corporation | 1 | $125 |
| Bristol Myers Squibb | 1 | $102 |
| Jazz Pharmaceuticals Inc. | 1 | $96 |
| Gilead | 1 | $92 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,016 in reported general payments places this provider in the 85th percentile of 321 acute care providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IclusigPonatinib Hcl | 12 | $226,680 |
| VenclextaVenetoclax | 11 | $72,320 |
| EliquisApixaban | 16 | $15,160 |
| Acyclovir | 37 | $731 |
| Allopurinol | 22 | $150 |
Paid to pharmacies, not to this prescriber.
Other acute care in Little Rock
- Jill AveryLittle Rock$117K
- Lynn FrazierLittle Rock$106K
- Beverly BaxterLittle Rock$95K
- Diane GlendinningLittle Rock$26K
- Beth CrowderLittle Rock$25K
- Carmen Paniagua TorresLittle Rock$21K
- Shana KloskeLittle Rock$14K
- Debra BrentLittle Rock$9K
- Ginger HartLittle Rock$9K
- Holly TrottaLittle Rock$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.